Citations

Mayo Clinic

Showing 10 of 108506 citations.

Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass
Law, Jennie H., Micheletto, Francesco, Sathananthan, Matheni, Man, Chiara Dalla , Rizza, Robert A., Camilleri, Michael , Zinsmeister, Alan R., Shah, Mithun V , Cobelli, Claudio , Vella, Adrian , Dalla Man, Chiara

Diabetes | October 3, 2013 | Volume: 63 | Issue: 2 | Pages: 483-493

10.2337/db13-0954 | PMID 24089513 Get It

The contribution of elevated glucagon-like peptide 1 (GLP-1) to postprandial glucose metabolism after Roux-en-Y gastric bypass (RYGB) has been the subject of uncertainty. We used exendin-9,39, a competitive antagonist of GLP-1, to examine glucose metabolism, islet hormone secretion, and gastrointestinal transit in subjects after RYGB and in matched control subjects. Subjects were studied in the presence or absence of exendin-9,39 infused at 300 pmol/kg/min. Exendin-9,39 resulted in an increase in integrated postprandial glucose concentrations post-RYGB (3.6 ± 0.5 vs. 2.0 ± 0.4 mol/6 h, P = 0.001). Exendin-9,39 decreased insulin concentrations (12.3 ± 2.2 vs. 18.1 ± 3.1 nmol/6 h, P = 0.002) and the β-cell response to glucose (ϕTotal, 13 ± 1 vs. 11 ± 1 × 10−9 min−1, P = 0.01) but did not alter the disposition index (DI). In control subjects, exendin-9,39 also increased glucose (2.2 ± 0.4 vs. 1.7 ± 0.3 mol/6 h, P = 0.03) without accompanying changes in insulin concentrations, resulting in an impaired DI. Post-RYGB, acceleration of stomach emptying during the first 30 min by exendin-9,39 did not alter meal appearance, and similarly, suppression of glucose production and stimulation of glucose disappearance were unaltered in RYGB subjects. These data indicate that endogenous GLP-1 has effects on glucose metabolism and on gastrointestinal motility years after RYGB. However, it remains uncertain whether this explains all of the changes after RYGB.
Predictors of Disseminated Intravascular Coagulation in Patients with Septic Shock
Kelm, Diana J. , Valerio-Rojas, Juan Carlos , Cabello-Garza, Javier, Cartin‐Ceba, Rodrigo , Gajic, Ognjen

ISRN Critical Care | October 2, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-6

10.5402/2013/219048 Get It

Purpose. The goal of this study was to identify potential clinical predictors for the development of disseminated intravascular coagulation (DIC) in patients with septic shock. Material and Methods. We performed a retrospective analysis of a cohort of adult (>18 years of age) patients with septic shock admitted to a medical ICU in a tertiary care hospital from July 2005 until September 2007. A multivariate logistic regression model was used to determine the association of risk factors with overt DIC. Results. In this study, a total of 390 patients with septic shock were analyzed, of whom 66 (17%) developed overt DIC. Hospital mortality was significantly greater in patients who developed overt DIC (68% versus 38%, P<0.001). A delay in the timing of antibiotics was associated with an increased risk of the development of overt DIC (P<0.001). Patients on antiplatelet therapy prior to hospital admission and who that received adequate early goal-directed therapy (EGDT) were associated with a decreased risk of overt DIC (P<0.001). Conclusions. In our cohort of patients with septic shock, there was a risk reduction for overt DIC in patients on antiplatelet therapy and adequate EGDT, while there was an increased risk of DIC with antibiotic delay.
Making Data on Essential Pharmacogenes Available for Every Patient Everywhere: The Medicine Safety Code Initiative
Samwald, Matthias , Freimuth, Robert R. , Freimuth, Robert R

Pharmacogenomics | October 2, 2013 | Volume: 14 | Issue: 13 | Pages: 1529-1531

10.2217/pgs.13.121 | PMID 24088121 Get It

Case Examples of Enhancing Pediatric OCD Treatment With a Smartphone Application
Whiteside, Stephen P. H. , Ale, Chelsea M. , Douglas, Kristin Vickers, Tiede, Michael S. , Dammann, Julie E.

Clinical Case Studies | October 1, 2013 | Volume: 13 | Issue: 1 | Pages: 80-94

10.1177/1534650113504822 Get It

These case examples depict the use of a smartphone application, Mayo Clinic Anxiety Coach, to enhance the treatment of pediatric obsessive-compulsive disorder (OCD). The presented cases highlight the use of Anxiety Coach as a stand-alone intervention for mild OCD symptoms and as an adjunct to treatment for severe OCD complicated by geographical barriers. Each case includes a description of treatment, patient use of the application, objective assessment of clinical symptoms, and a qualitative interview with the families. Both patients responded well to treatment and had a positive experience with Anxiety Coach. The application encouraged the families to complete exposures between sessions and allowed a detailed examination of the patients’ engagement in homework assignments. Potential uses of smartphone applications to address challenges facing treatment of, and research on, OCD are discussed.
Correction for a Potentially Biased Item on the Mattis Dementia Rating Scale
Dean, P.M. , Cerhan, Jane H.

American Journal of Alzheimer's Disease & Other Dementias® | October 1, 2013 | Volume: 28 | Issue: 8 | Pages: 734-737

10.1177/1533317513504610 | PMID 24085248 Get It

The Mattis Dementia Rating Scale (MDRS) is a multidimensional cognitive measure popular with clinicians for its brevity, diagnostic validity, and utility in monitoring impairment severity. In spite of the test’s significant value, one task can cause discomfort because the patient is asked to name items the examiner is wearing. This task also creates possible cultural bias and standardization issues. We studied 102 MDRS profiles that included this item. Adjusted scores were calculated by giving all patients full credit for the apparel-naming item. The average adjustment was just one point, and the resulting dementia-severity ratings remained unchanged in 97% of the patients. These results show that administration of the item can be defensibly skipped if there is concern about its appropriateness with an individual patient. The adjusted scores provide a viable and fair alternative that preserves the psychometric properties of this useful instrument.
A Polymeric Fastener Can Easily Functionalize Liposome Surfaces with Gadolinium for Enhanced Magnetic Resonance Imaging
Smith, Cartney E., Shkumatov, Artem, Withers, Sarah G., Yang, Binxia , Glockner, James F., Roy, Edward J. , Wong, Chun‐Ho , Zimmerman, Steven C. , Kong, Hyunjoon , Misra, Sanjay , Misra, Sanjay , Kong, Hyunjoon , Misra, Sanjay

ACS Nano | October 1, 2013 | Volume: 7 | Issue: 11 | Pages: 9599-9610

10.1021/nn4026228 | PMID 24083377 Get It

Faculty Opinions recommendation of Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.
Dibaise, John

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | October 1, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718016332.793484363 Get It

Faculty Opinions recommendation of Nur77 suppresses pulmonary artery smooth muscle cell proliferation through inhibition of the STAT3/Pim-1/NFAT pathway.
Martin, Yvette N. , Prakash, Y. S.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | October 1, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718114370.793484306 Get It

Letter to the Editor: Comparative effectiveness of treatments for cerebral arteriovenous malformations
Cloft, Harry J.

Neurosurgical Focus | October 1, 2013 | Volume: 35 | Issue: 4 | Pages: E5

10.3171/2012.8.focus12293 | PMID 24079784 Get It

Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010
Banerjee, Ritu , Robicsek, Ari , Kuskowski, Michael A., Porter, Stephen B. , Johnston, Brian , Sokurenko, Evgeni V. , Tchesnokova, Veronika , Price, Lance B. , Johnson, James R.

Antimicrobial Agents and Chemotherapy | October 1, 2013 | Volume: 57 | Issue: 12 | Pages: 6385-6388

10.1128/aac.01604-13 | PMID 24080662 Get It

ABSTRACT We assessed Escherichia coli ST131 and its H30 and H30-Rx subclones for virulence genes, antimicrobial resistance, and extended-spectrum beta-lactamase (ESBL) type. Although both subclones were associated with ESBL production, H30-Rx isolates had higher resistance scores and were associated specifically with CTX-M-15. Three virulence genes ( iha , sat , and iutA ) were more prevalent among H30 than non-H30 ST131 isolates. Thus, the H30 and H30-Rx subclones are more antimicrobial resistant and have virulence profiles that are distinct from those of non-H30 ST131 isolates.